Pink Sheet is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

NAD agrees with most Prehistin supplement claims

This article was originally published in The Tan Sheet

Executive Summary

Cobalis Corp. supports most print advertising claims that its Prehistin dietary supplement works by raising serum B12 levels and lowering serum levels of immunoglobulin E, which plays a role in allergy response, according to a recent National Advertising Division review. Supported claims included the product is an "all-natural formula," it is "free of side effects" and "has been shown to effectively regulate IgE levels in individuals while significantly increasing serum vitamin B12 levels." However, the watchdog group recommended the Irvine, Calif.-based advertiser discontinue the claim that the product works for "weeks after you stop taking it" and that it is "allergist recommended." The company agreed to comply with NAD's recommendations
Advertisement

Topics

Advertisement
UsernamePublicRestriction

Register

PS103752

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel